Bernadette Ballard-Reid
https://happeortho.com/fda-clearance-integrate-c/
https://www.onltherapeutics.com/2023/04/12/onl-therapeutics-announces-first-patient-dosed-in-phase-2-clinical-trial-of-first-in-class-fas-inhibitor-in-patients-with-macula-off-rhegmatogenous-retinal-detachment/
https://shoulderinnovations.com/nasdaq-celebrates-shoulder-innovations/
https://shoulderinnovations.com/oversubscribed-42-million-series-d/
https://investors.seastarmedical.com/news/news-details/2023/SeaStar-Medical-Holding-Corporation-Closes-Initial-3.3-Million-Tranche-of-9.8-Million-Private-Placement/default.aspx
https://www.ocuphire.com/news-media/press-releases/detail/396/ocuphire-announces-fda-acceptance-of-new-drug-application
https://fiftheye.com/2023/03/02/fifth-eye-again-named-to-top-ten-artificial-intelligence-solutions-provider/
https://greenmark.bio/news-events/bdj-online-evaluation-of-a-novel-caries-detecting-oral-rinse/
https://greenmark.bio/news-events/greenmark-biomedical-wins-2023-yankee-dental-meeting/
https://www.vestaron.com
https://www.evoqtherapeutics.com/publications
https://fiftheye.com/2022/09/20/fifth-eyes-quality-management-system-receives-iso-134852016-and-mdsap-certifications/
https://www.ocuphire.com/news-media/press-releases/detail/391/ocuphire-pharma-enters-into-a-global-license-agreement-for
https://www.vestaron.com/vestaron-closes-series-c-funding-at-82m/
